| Product Code: ETC7747091 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Rare Biomarkers Specimen Collection and Stabilization Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Rare Biomarkers Specimen Collection and Stabilization Market - Industry Life Cycle |
3.4 Japan Rare Biomarkers Specimen Collection and Stabilization Market - Porter's Five Forces |
3.5 Japan Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Japan Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 Japan Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume Share, By Specimen, 2021 & 2031F |
3.8 Japan Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume Share, By Nucleic Acid and other Biomolecules, 2021 & 2031F |
3.9 Japan Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.10 Japan Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume Share, By End use, 2021 & 2031F |
4 Japan Rare Biomarkers Specimen Collection and Stabilization Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing focus on precision medicine and personalized healthcare |
4.2.2 Growing demand for biomarker-based diagnostics and therapies |
4.2.3 Technological advancements in specimen collection and stabilization techniques |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for rare biomarker specimen collection and handling |
4.3.2 Limited awareness and understanding of rare biomarkers among healthcare professionals |
4.3.3 High costs associated with rare biomarker specimen collection and stabilization |
5 Japan Rare Biomarkers Specimen Collection and Stabilization Market Trends |
6 Japan Rare Biomarkers Specimen Collection and Stabilization Market, By Types |
6.1 Japan Rare Biomarkers Specimen Collection and Stabilization Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Japan Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Japan Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Circulating Cell Free DNA (ccfDNA), 2021- 2031F |
6.1.4 Japan Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Circulating Tumor Cells (CTCs), 2021- 2031F |
6.1.5 Japan Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Exosomes/Extracellular Vesicles, 2021- 2031F |
6.2 Japan Rare Biomarkers Specimen Collection and Stabilization Market, By Product |
6.2.1 Overview and Analysis |
6.2.2 Japan Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Isolation Kits and Reagents, 2021- 2031F |
6.2.3 Japan Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Blood Collection Tubes, 2021- 2031F |
6.2.4 Japan Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Systems, 2021- 2031F |
6.3 Japan Rare Biomarkers Specimen Collection and Stabilization Market, By Specimen |
6.3.1 Overview and Analysis |
6.3.2 Japan Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Serum/Plasma, 2021- 2031F |
6.3.3 Japan Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Japan Rare Biomarkers Specimen Collection and Stabilization Market, By Nucleic Acid and other Biomolecules |
6.4.1 Overview and Analysis |
6.4.2 Japan Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By RNA, 2021- 2031F |
6.4.3 Japan Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By DNA, 2021- 2031F |
6.4.4 Japan Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Japan Rare Biomarkers Specimen Collection and Stabilization Market, By Application |
6.5.1 Overview and Analysis |
6.5.2 Japan Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By NIPT, 2021- 2031F |
6.5.3 Japan Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Oncology, 2021- 2031F |
6.5.4 Japan Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Transcriptomics, 2021- 2031F |
6.5.5 Japan Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Pharmacogenomics, 2021- 2031F |
6.5.6 Japan Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Transplant Rejection, 2021- 2031F |
6.5.7 Japan Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Population Screening, 2021- 2031F |
6.5.8 Japan Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Others, 2021- 2031F |
6.5.9 Japan Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Japan Rare Biomarkers Specimen Collection and Stabilization Market, By End use |
6.6.1 Overview and Analysis |
6.6.2 Japan Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 Japan Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Perinatal Clinics, 2021- 2031F |
6.6.4 Japan Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Public Health Labs, 2021- 2031F |
6.6.5 Japan Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Private or Commercial Labs, 2021- 2031F |
6.6.6 Japan Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Physician Labs, 2021- 2031F |
6.6.7 Japan Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Research Institutes, 2021- 2031F |
7 Japan Rare Biomarkers Specimen Collection and Stabilization Market Import-Export Trade Statistics |
7.1 Japan Rare Biomarkers Specimen Collection and Stabilization Market Export to Major Countries |
7.2 Japan Rare Biomarkers Specimen Collection and Stabilization Market Imports from Major Countries |
8 Japan Rare Biomarkers Specimen Collection and Stabilization Market Key Performance Indicators |
8.1 Adoption rate of rare biomarker collection and stabilization technologies |
8.2 Number of research studies and clinical trials utilizing rare biomarkers |
8.3 Rate of integration of rare biomarker data into diagnostic and therapeutic decision-making |
9 Japan Rare Biomarkers Specimen Collection and Stabilization Market - Opportunity Assessment |
9.1 Japan Rare Biomarkers Specimen Collection and Stabilization Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Japan Rare Biomarkers Specimen Collection and Stabilization Market Opportunity Assessment, By Product, 2021 & 2031F |
9.3 Japan Rare Biomarkers Specimen Collection and Stabilization Market Opportunity Assessment, By Specimen, 2021 & 2031F |
9.4 Japan Rare Biomarkers Specimen Collection and Stabilization Market Opportunity Assessment, By Nucleic Acid and other Biomolecules, 2021 & 2031F |
9.5 Japan Rare Biomarkers Specimen Collection and Stabilization Market Opportunity Assessment, By Application, 2021 & 2031F |
9.6 Japan Rare Biomarkers Specimen Collection and Stabilization Market Opportunity Assessment, By End use, 2021 & 2031F |
10 Japan Rare Biomarkers Specimen Collection and Stabilization Market - Competitive Landscape |
10.1 Japan Rare Biomarkers Specimen Collection and Stabilization Market Revenue Share, By Companies, 2024 |
10.2 Japan Rare Biomarkers Specimen Collection and Stabilization Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here